Search research articles
Contact Us
Filters
Showing results (91-100 of 118) with videos related to
Page
of 12
Sort By:
Frontiers in Oncology
|
October 31, 2022
Deep learning-based growth prediction for sub-solid pulmonary nodules on CT images
Ri-Qiang Liao, An-Wei Li, Hong-Hong Yan, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
November 17, 2023
Lack of incremental value of three-dimensional measurement in assessing invasiveness for lung cancer
Meng-Min Wang, Jia-Qi Li, Shi-Hua Dou, et al.
Annals of Nuclear Medicine
|
December 25, 2023
Impact of preoperative [<sup>18</sup>F]FDG PET/CT vs. contrast-enhanced CT in the staging and survival of patients with clinical stage I and II non-small cell lung cancer: a 10-year follow-up study
Jun-Tao Lin, Xiang-Meng Li, Wen-Zhao Zhong, et al.
Ebiomedicine
|
April 28, 2019
Analysis of resistance mechanisms to abivertinib, a third-generation EGFR tyrosine kinase inhibitor, in patients with EGFR T790M-positive non-small cell lung cancer from a phase I trial
Yi-Chen Zhang, Zhi-Hong Chen, Xu-Chao Zhang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 20, 2019
Clinical Utility of Cerebrospinal Fluid Cell-Free DNA as Liquid Biopsy for Leptomeningeal Metastases in ALK-Rearranged NSCLC
Mei-Mei Zheng, Yang-Si Li, Ben-Yuan Jiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 1, 2017
Potential Predictive Value of <i>TP53</i> and <i>KRAS</i> Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung Adenocarcinoma
Zhong-Yi Dong, Wen-Zhao Zhong, Xu-Chao Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 14, 2019
Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Treatment of Stage IIIA-N2 <i>EGFR</i>-Mutant Non-Small-Cell Lung Cancer (EMERGING-CTONG 1103): A Randomized Phase II Study
Wen-Zhao Zhong, Ke-Neng Chen, Chun Chen, et al.
Cell Reports. Medicine
|
January 19, 2023
Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: A real-world study
Han-Min Wang, Chan-Yuan Zhang, Kai-Cheng Peng, et al.
Science Bulletin
|
January 7, 2024
PD-L1 expression guidance on sintilimab versus pembrolizumab with or without platinum-doublet chemotherapy in untreated patients with advanced non-small cell lung cancer (CTONG1901): A phase 2, randomized, controlled trial
Si-Yang Maggie Liu, Jie Huang, Jia-Yi Deng, et al.
Signal Transduction and Targeted Therapy
|
December 6, 2023
Neoadjuvant nivolumab with or without platinum-doublet chemotherapy based on PD-L1 expression in resectable NSCLC (CTONG1804): a multicenter open-label phase II study
Si-Yang Liu, Song Dong, Xue-Ning Yang, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 118) with videos related to
Sort By:
Page
of 12
Frontiers in Oncology
|
October 31, 2022
Deep learning-based growth prediction for sub-solid pulmonary nodules on CT images
Ri-Qiang Liao, An-Wei Li, Hong-Hong Yan, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
November 17, 2023
Lack of incremental value of three-dimensional measurement in assessing invasiveness for lung cancer
Meng-Min Wang, Jia-Qi Li, Shi-Hua Dou, et al.
Annals of Nuclear Medicine
|
December 25, 2023
Impact of preoperative [<sup>18</sup>F]FDG PET/CT vs. contrast-enhanced CT in the staging and survival of patients with clinical stage I and II non-small cell lung cancer: a 10-year follow-up study
Jun-Tao Lin, Xiang-Meng Li, Wen-Zhao Zhong, et al.
Ebiomedicine
|
April 28, 2019
Analysis of resistance mechanisms to abivertinib, a third-generation EGFR tyrosine kinase inhibitor, in patients with EGFR T790M-positive non-small cell lung cancer from a phase I trial
Yi-Chen Zhang, Zhi-Hong Chen, Xu-Chao Zhang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 20, 2019
Clinical Utility of Cerebrospinal Fluid Cell-Free DNA as Liquid Biopsy for Leptomeningeal Metastases in ALK-Rearranged NSCLC
Mei-Mei Zheng, Yang-Si Li, Ben-Yuan Jiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 1, 2017
Potential Predictive Value of <i>TP53</i> and <i>KRAS</i> Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung Adenocarcinoma
Zhong-Yi Dong, Wen-Zhao Zhong, Xu-Chao Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 14, 2019
Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Treatment of Stage IIIA-N2 <i>EGFR</i>-Mutant Non-Small-Cell Lung Cancer (EMERGING-CTONG 1103): A Randomized Phase II Study
Wen-Zhao Zhong, Ke-Neng Chen, Chun Chen, et al.
Cell Reports. Medicine
|
January 19, 2023
Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: A real-world study
Han-Min Wang, Chan-Yuan Zhang, Kai-Cheng Peng, et al.
Science Bulletin
|
January 7, 2024
PD-L1 expression guidance on sintilimab versus pembrolizumab with or without platinum-doublet chemotherapy in untreated patients with advanced non-small cell lung cancer (CTONG1901): A phase 2, randomized, controlled trial
Si-Yang Maggie Liu, Jie Huang, Jia-Yi Deng, et al.
Signal Transduction and Targeted Therapy
|
December 6, 2023
Neoadjuvant nivolumab with or without platinum-doublet chemotherapy based on PD-L1 expression in resectable NSCLC (CTONG1804): a multicenter open-label phase II study
Si-Yang Liu, Song Dong, Xue-Ning Yang, et al.
Page
of 12